Drotrecogin alfa (activated)
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
151 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sepsis | D018805 | EFO_0001420 | A41.9 | — | 2 | 5 | 5 | 9 | 21 |
| Toxemia | D014115 | — | — | — | 1 | 2 | 2 | 3 | 8 |
| Septic shock | D012772 | — | A48.3 | — | 1 | 2 | 2 | 3 | 8 |
| Colorectal neoplasms | D015179 | — | — | 4 | 2 | — | 1 | — | 6 |
| Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | — | — | — | 1 | 5 | 6 |
| Hematologic neoplasms | D019337 | — | — | 2 | 3 | — | 1 | — | 5 |
| Hemostatic disorders | D020141 | — | — | — | — | — | 1 | 4 | 5 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | 1 | — | 1 | 3 | 5 |
| Shock | D012769 | — | R57.1 | — | — | — | 2 | — | 2 |
| Intracranial hemorrhages | D020300 | EFO_0000551 | I62 | — | — | — | 1 | 1 | 2 |
Show 3 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 5 | 4 | 2 | — | — | 9 |
| Lymphoma | D008223 | — | C85.9 | 3 | 4 | 1 | — | — | 8 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 2 | 1 | — | 1 | 6 |
| Recurrence | D012008 | — | — | 2 | 3 | 1 | — | 2 | 6 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 2 | 1 | — | 2 | 5 |
| Hemophilia a | D006467 | EFO_0007267 | D66 | — | 2 | 1 | — | 2 | 5 |
| Protein c deficiency | D020151 | EFO_0009316 | D68.59 | 1 | 2 | 1 | — | 3 | 5 |
| Chronic renal insufficiency | D051436 | — | N18 | 1 | — | 1 | — | 2 | 4 |
| Lung neoplasms | D008175 | — | C34.90 | — | 3 | 1 | — | — | 3 |
| Hepatitis c | D006526 | — | B19.2 | — | 2 | 1 | — | 1 | 3 |
Show 12 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 10 | 3 | — | — | 2 | 12 |
| Melanoma | D008545 | — | — | 4 | 9 | — | — | — | 10 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 4 | 2 | — | — | — | 5 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 3 | 1 | — | — | — | 4 |
| Multiple myeloma | D009101 | — | C90.0 | 3 | 1 | — | — | — | 4 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 2 | 2 | — | — | 1 | 4 |
| Leukemia | D007938 | — | C95 | 2 | 1 | — | — | 1 | 4 |
| Healthy volunteers/patients | — | — | — | 3 | 1 | — | — | 1 | 4 |
| Covid-19 | D000086382 | — | U07.1 | 1 | 1 | — | — | 2 | 4 |
| Head and neck neoplasms | D006258 | — | — | 2 | 1 | — | — | — | 3 |
Show 51 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neuroblastoma | D009447 | EFO_0000621 | — | 2 | — | — | — | — | 2 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 2 | — | — | — | — | 2 |
| Myeloid leukemia | D007951 | — | C92 | 2 | — | — | — | — | 2 |
| Plasma cell neoplasms | D054219 | — | — | 2 | — | — | — | — | 2 |
| Syndrome | D013577 | — | — | 1 | — | — | — | 1 | 2 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | — | 1 |
| Glioblastoma | D005909 | EFO_0000515 | — | 1 | — | — | — | — | 1 |
| Central nervous system neoplasms | D016543 | — | — | 1 | — | — | — | — | 1 |
| Germ cell and embryonal neoplasms | D009373 | — | — | 1 | — | — | — | — | 1 |
| Medulloblastoma | D008527 | — | — | 1 | — | — | — | — | 1 |
Show 19 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Venous thromboembolism | D054556 | EFO_0004286 | I74 | — | — | — | — | 3 | 3 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 2 | 2 |
| Portal hypertension | D006975 | EFO_0000666 | K76.6 | — | — | — | — | 2 | 2 |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | — | — | — | 2 | 2 |
| Sclerosis | D012598 | — | — | — | — | — | — | 2 | 2 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | — | — | 2 | 2 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 2 | 2 |
| Venous thrombosis | D020246 | — | I82.40 | — | — | — | — | 2 | 2 |
| Coronary disease | D003327 | — | — | — | — | — | — | 2 | 2 |
| Coronary artery disease | D003324 | — | I25.1 | — | — | — | — | 2 | 2 |
Show 68 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 13,063 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,371 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use